CORT Earnings Corcept Therapeutics Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–42 of 42
| Q2 2026 | 2026-06-30 | 0.09 | 2026-07-29 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.30 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | 0.82 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | 0.62 | 2025-11-04 | 10-Q |
| Q2 2026 | 2025-06-30 | 0.46 | 2026-07-29 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.17 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | 1.23 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | 0.98 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.57 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.25 | 2025-05-05 | 10-Q |
| FY 2025 | 2023-12-31 | 0.94 | 2026-02-24 | 10-K |
| Q3 2024 | 2023-09-30 | 0.66 | 2024-10-30 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.38 | 2024-07-29 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.14 | 2024-05-01 | 10-Q |
| FY 2024 | 2022-12-31 | 0.87 | 2025-02-26 | 10-K |
| Q3 2023 | 2022-09-30 | 0.73 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.44 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.20 | 2023-05-03 | 10-Q |
| FY 2023 | 2021-12-31 | 0.89 | 2024-02-15 | 10-K |
| Q3 2022 | 2021-09-30 | 0.63 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.39 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.18 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | 0.85 | 2023-02-28 | 10-K |
| Q3 2021 | 2020-09-30 | 0.65 | 2021-11-03 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.48 | 2021-07-29 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.25 | 2021-05-06 | 10-Q |
| FY 2021 | 2019-12-31 | 0.77 | 2022-02-15 | 10-K |
| FY 2020 | 2019-09-30 | 0.22 | 2021-02-23 | 10-K |
| FY 2020 | 2019-06-30 | 0.17 | 2021-02-23 | 10-K |
| FY 2020 | 2019-03-31 | 0.15 | 2021-02-23 | 10-K |
| FY 2020 | 2018-12-31 | 0.60 | 2021-02-23 | 10-K |
| FY 2019 | 2018-09-30 | 0.14 | 2020-02-24 | 10-K |
| FY 2019 | 2018-06-30 | 0.14 | 2020-02-24 | 10-K |
| FY 2019 | 2018-03-31 | 0.14 | 2020-02-24 | 10-K |
| FY 2019 | 2017-12-31 | 1.04 | 2020-02-24 | 10-K |
| FY 2018 | 2017-09-30 | 0.11 | 2019-02-26 | 10-K |
| FY 2018 | 2017-06-30 | 0.10 | 2019-02-26 | 10-K |
| FY 2018 | 2017-03-31 | 0.04 | 2019-02-26 | 10-K |
| FY 2018 | 2016-12-31 | 0.07 | 2019-02-26 | 10-K |
| Q3 2017 | 2016-09-30 | 0.03 | 2017-11-03 | 10-Q |
| Q2 2017 | 2016-06-30 | 0.01 | 2017-08-02 | 10-Q |
| FY 2017 | 2015-12-31 | -0.06 | 2018-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.